Hemosiderosis

10 registered clinical trials studyying Hemosiderosis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogene NCT07028112	Assistance Publique - Hôpitaux de Paris	—
Terminated	The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients NCT04284371	The Geneva Foundation	—
Completed	Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content NCT02025543	University of Wisconsin, Madison	—
Completed	Non-invasive Quantification of Liver Iron With MRI NCT01516853	University of Wisconsin, Madison	—
Completed	Pharmacogenetic Study in Patients Received Iron Chelating Agent NCT01623895	Seoul National University Hospital	—
Completed	Safety, Tolerability, and Efficacy of Deferasirox in MDS NCT00469560	Gruppo Italiano Malattie EMatologiche dell'Adulto	Phase 3
Completed	Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfus NCT00171301	Novartis Pharmaceuticals	Phase 4
Completed	A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosidero NCT00171171	Novartis	Phase 3
Completed	Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients NCT00303329	Novartis Pharmaceuticals	Phase 2
Completed	Efficacy Study in Removing Excess Iron From the Heart NCT00105495	ApoPharma	Phase 4